Search for: "Teva Pharmaceuticals USA, Inc."
Results 221 - 240
of 489
Sorted by Relevance
|
Sort by Date
17 May 2007, 9:09 am
Teva Pharmaceuticals USA Inc., No. 06-0282, 22 BNA Toxic Law Rptr. #20 (S.D. [read post]
20 Feb 2013, 7:37 am
Teva Pharmaceuticals USA Inc., et. al., 1-10-cv-00805 (DED February 11, 2013, Order) (Burke, M.J.). [read post]
30 Mar 2018, 7:13 am
Teva Pharmaceuticals USA, Inc., 1-14-cv-00878 (DED March 28, 2018, Order) (Stark, USDJ) [read post]
18 Jul 2018, 11:23 am
Teva Pharmaceuticals USA, Inc., a case with broad implications for the pharmaceutical industry. [read post]
2 Oct 2013, 8:58 am
Teva Pharmaceuticals USA et al. [read post]
23 Jan 2024, 3:43 am
Teva Pharmaceuticals USA, Inc., 23-768 (Supreme Court). [read post]
29 Mar 2016, 7:21 am
Reinstein agreed to switch his patients to the generic version, but only after its manufacturers, Teva Pharmaceuticals USA Inc. and IVAX Pharmaceuticals LLC, agreed to pay him a consulting fee and finance a Clozapine research study performed by a Reinstein-affiliated entity. [read post]
28 Aug 2009, 8:11 am
Teva Pharmaceuticals USA, Inc. [read post]
21 Apr 2014, 6:01 am
The cost for medical delivery far exceeds indemnification for temporary and permanent disability benefits.The court's action, albeit temporary in nature, maybe a signal of forthcoming judicial intervention in the pharmaceutical arena that will result in a more realistic cost for pharmaceutical benefits in workers' compensation.Teva Pharmaceuticals USA, Inc., et al., Petitioners v.Sandoz, Inc., et al. [read post]
1 Apr 2007, 6:14 pm
Noonan --- In its MedImmune, Inc. v. [read post]
23 Jul 2018, 12:05 pm
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229. [read post]
8 Jun 2017, 3:27 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
13 Jun 2017, 12:00 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
13 Jun 2017, 12:00 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
28 Mar 2019, 9:07 am
Teva Pharmaceuticals USA, Inc. [read post]
19 Jun 2019, 6:18 am
Teva Pharmaceuticals USA, Inc. [read post]
25 Jun 2018, 7:03 am
Teva Pharmaceuticals USA Inc., Docket No. 17-1229. [read post]
17 Oct 2014, 5:09 pm
Stephens Teva Pharmaceuticals USA, Inc., v. [read post]
22 Jan 2015, 9:56 pm
USA, Inc. v. [read post]
2 Nov 2020, 1:41 pm
Teva Pharmaceuticals USA, Inc., is getting attention for potentially “endangering” the practice of skinny labelling. [read post]
